Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

Clinical trial NCT06364410 · RECRUITING

Trial details

NCT number: NCT06364410
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage III Gastric Cancer AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IV Gastric Cancer AJCC v8 Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Locally Advanced Gastric Carcinoma Locally Advanced Gastroesophageal Junction Adenocarcinoma Locally Advanced Malignant Solid Neoplasm Metastatic Gastric Carcinoma Metastatic Gastroesophageal Junction Adenocarcinoma Metastatic Malignant Solid Neoplasm Unresectable Gastric Carcinoma Unresectable Gastroesophageal Junction Adenocarcinoma

Start date: 2025-02-03
Primary completion: 2027-07-08
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.